Journal
Vaccines
Publication Date
5-14-2024
Volume
12
Issue
5
First Page
535
Document Type
Open Access Publication
DOI
10.3390/vaccines12050535
Rights and Permissions
Saz-Leal P, Ligon MM, Diez-Rivero CM, García-Ayuso D, Mohanty S, Viñuela M, Real-Arévalo I, Conejero L, Brauner A, Subiza JL, Mysorekar IU. MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines (Basel). 2024 May 14;12(5):535. doi: 10.3390/vaccines12050535 Copyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Saz-Leal, Paula; Ligon, Marianne Morris; Diez-Rivero, Carmen María; García-Ayuso, Diego; Mohanty, Soumitra; Viñuela, Marcos; Real-Arévalo, Irene; Conejero, Laura; Brauner, Annelie; Subiza, José Luis; and Mysorekar, Indira Uppugunduri, "MV140 mucosal vaccine induces targeted immune response for enhanced clearance of uropathogenic E. coli in experimental urinary tract infection." Vaccines. 12, 5. 535 (2024).
https://digitalcommons.wustl.edu/oa_4/3834
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
